Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.

Ceccato, F; Vedolin, C K; Voltan, G; Antonelli, G; Barbot, M; Basso, D; Regazzo, D; Scaroni, C; Occhi, G

Ceccato, F; Vedolin, C K; Voltan, G; Antonelli, G; Barbot, M; Basso, D; Regazzo, D; Scaroni, C; Occhi, G.

Afiliación

Ceccato F; Department of Medicine DIMED, University of Padova, Padua, Italy.
Vedolin CK; Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.
Voltan G; Department of Medicine DIMED, University of Padova, Padua, Italy.
Antonelli G; Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.
Barbot M; Department of Medicine DIMED, University of Padova, Padua, Italy.
Basso D; Endocrine Disease Unit, University-Hospital of Padova, Padua, Italy.
Regazzo D; Department of Medicine DIMED, University of Padova, Padua, Italy.
Scaroni C; Laboratory Medicine, University-Hospital of Padova, Padua, Italy.
Occhi G; Department of Medicine DIMED, University of Padova, Padua, Italy.

J Endocrinol Invest ; 47(1): 213-221, 2024 Jan.

Article en En | MEDLINE | ID: mdl-37344722

Asunto(s)

Acromegalia; Hormona de Crecimiento Humana; Humanos; Acromegalia/epidemiología; Acromegalia/metabolismo; Glucosa/metabolismo; Factor I del Crecimiento Similar a la Insulina/metabolismo; Hormona de Crecimiento Humana/metabolismo; Estudios de Casos y Controles

Palabras clave

Acromegaly, IGF-1; GIP; Oral glucose tolerance test; Paradoxical response

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Acromegalia / Hormona de Crecimiento Humana Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google